16344317Byrd JC, Gribben JG, Peterson BL, Grever MR, Lozanski G, Lucas DM, Lampson B, Larson RA, Caligiuri MA, Heerema NAJournal of clinical oncology : official journal of the American Society of Clinical OncologyAntineoplastic Combined Chemotherapy Protocols; Gene Deletion; Genes, Immunoglobulin Heavy Chain; Leukemia, Lymphocytic, Chronic, B-Cell; Mutation; Tumor Suppressor Protein p53Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 17; Clinical Trials, Phase II as Topic; Disease Progression; Disease-Free Survival; Female; Genetic Predisposition to Disease; Humans; Immunologic Factors; Male; Middle Aged; Predictive Value of Tests; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Rituximab; VidarabineSelect high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy. J Clin Oncol. 2006 Jan 20; 24(3):437-43.J Clin Oncol2005-12-12T00:00:002005Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000368Living Beings1341183530.294764AgedD000328Living Beings1578255770.254432AdultD000971Procedures30624340.476235Antineoplastic Combined Chemotherapy ProtocolsD002880Anatomy461060.971356Chromosomes, Human, Pair 11D000911Chemicals & Drugs33713760.622749Antibodies, MonoclonalD007155Chemicals & Drugs921700.875285Immunologic FactorsD002886Anatomy501100.95703Chromosomes, Human, Pair 17D008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD009154Physiology70239520.442648MutationAuthorship 285328D005260Physiology1992444050.191167FemaleD012307Concepts & Ideas94153970.464223Risk FactorsD006801Living Beings2262862810.130052HumansD015451Disorders571360.907606Leukemia, Lymphocytic, Chronic, B-CellD008297Physiology1931408600.201617MaleD016032Concepts & IdeasProcedures2778500.730116Randomized Controlled Trials as TopicD018570Concepts & IdeasProcedures62722530.57096Risk AssessmentD014740Chemicals & Drugs191410.950579VidarabineMedicine-Hematology and OncologyD017322Activities & BehaviorsProcedures661730.916814Clinical Trials, Phase II as TopicD017353Physiology1973280.888117Gene DeletionD018450Physiology49815310.700842Disease Progression0.07035720.07035721authors10.2528has subject areaD011379Procedures74536690.561447PrognosisD058846Chemicals & Drugs53780.969619Antibodies, Monoclonal, Murine-DerivedD000069283671160.945252RituximabD011237Concepts & Ideas53616710.69603Predictive Value of TestsD016159Chemicals & Drugs1783800.816799Tumor Suppressor Protein p53D018572Concepts & Ideas25812030.792696Disease-Free SurvivalD020022Physiology39922670.521961Genetic Predisposition to DiseaseD050438Genes & Molecular Sequences890.994307Genes, Immunoglobulin Heavy ChainUniversity of ChicagoRichard A.LarsonRichard A. Larson41.78927490000000-87.601250000000001169Larson, Richard A.Professortrue1ProfessorProfessor